Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Bokemeyer

Showing results (411-420 of 664) with videos related to

Pageof 67
Sort By:
Haematologica|February 22, 2008
CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantationDjordje Atanackovic, Yanran Cao, Tim Luetkens, et al.
Pathology|July 10, 2012
Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancerSarah Minner, Colin De Silva, Michael Rink, et al.
BJU International|October 20, 2010
Histopathological and molecular features of late relapses in non-seminomasFrank Mayer, Hendrik Wermann, Peter Albers, et al.
Frontiers in Oncology|February 11, 2020
Cancer Cells Expressing Oncogenic Rat Sarcoma Show Drug-Addiction Toward Epidermal Growth Factor Receptor Antibodies Mediated by Sustained MAPK SignalingJoseph Tintelnot, Sina Metz, Marie Trentmann, et al.
International Journal of Cancer|July 20, 2024
Applications of Nanopore sequencing in precision cancer medicineSergey A Dyshlovoy, Stefanie Paigin, Ann-Kristin Afflerbach, et al.
Thrombosis Research|March 12, 2016
Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancerCarlota Claussen, Alma-Verena Rausch, Susanne Lezius, et al.
Cancer Research|January 7, 2006
Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignanciesMarcus M Schittenhelm, Sharon Shiraga, Arin Schroeder, et al.
Blood|July 9, 2015
The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosisKatrin F Nickel, Göran Ronquist, Florian Langer, et al.
Genes, Chromosomes & Cancer|December 7, 2013
Continuous tissue microarray based identification of cancers with homogeneous target expression for successful targeted therapy in clinical routine practiceEike Burandt, Melanie Schreiber, Alexander Stein, et al.
Journal of Proteome Research|July 23, 2008
Comparative proteome, transcriptome, and genome analysis of a gonadal and an extragonadal germ cell tumor cell lineStephanie Glaesener, Friedemann Honecker, Imke M Veltman, et al.
Pageof 67

Showing results (411-420 of 664) with videos related to

Sort By:
Pageof 67
Haematologica|February 22, 2008
CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantationDjordje Atanackovic, Yanran Cao, Tim Luetkens, et al.
Pathology|July 10, 2012
Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancerSarah Minner, Colin De Silva, Michael Rink, et al.
BJU International|October 20, 2010
Histopathological and molecular features of late relapses in non-seminomasFrank Mayer, Hendrik Wermann, Peter Albers, et al.
Frontiers in Oncology|February 11, 2020
Cancer Cells Expressing Oncogenic Rat Sarcoma Show Drug-Addiction Toward Epidermal Growth Factor Receptor Antibodies Mediated by Sustained MAPK SignalingJoseph Tintelnot, Sina Metz, Marie Trentmann, et al.
International Journal of Cancer|July 20, 2024
Applications of Nanopore sequencing in precision cancer medicineSergey A Dyshlovoy, Stefanie Paigin, Ann-Kristin Afflerbach, et al.
Thrombosis Research|March 12, 2016
Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancerCarlota Claussen, Alma-Verena Rausch, Susanne Lezius, et al.
Cancer Research|January 7, 2006
Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignanciesMarcus M Schittenhelm, Sharon Shiraga, Arin Schroeder, et al.
Blood|July 9, 2015
The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosisKatrin F Nickel, Göran Ronquist, Florian Langer, et al.
Genes, Chromosomes & Cancer|December 7, 2013
Continuous tissue microarray based identification of cancers with homogeneous target expression for successful targeted therapy in clinical routine practiceEike Burandt, Melanie Schreiber, Alexander Stein, et al.
Journal of Proteome Research|July 23, 2008
Comparative proteome, transcriptome, and genome analysis of a gonadal and an extragonadal germ cell tumor cell lineStephanie Glaesener, Friedemann Honecker, Imke M Veltman, et al.
Pageof 67